Synaptive Medical Inc., a global medical technology innovator, is pleased to announce the inaugural installation of its next-generation robotic exoscope, Modus X in Europe. This highly anticipated exoscope delivers a leap forward for surgical visualization in neurosurgery, ENT, plastics, and spine procedures, and it has made its European debut at Azienda Ospedaliera Universitaria Federico II in Naples, Italy.

Azienda Ospedaliera Universitaria Federico II, is a distinguished institution affiliated with Federico II University Hospital. This strategic placement in one of Italy's foremost medical facilities signifies a significant advancement in surgical technology and patient care.

Modus X, introduced in the summer of 2023, boasts an array of cutting-edge features, including redesigned 4K 3D optics, 27x magnification, robotic camera alignment, and voice guidance. This innovative platform also introduces fluorescence-guided surgery for enhanced tissue differentiation. Furthermore, the flexible design of Modus X allows for seamless field upgrades from Modus V, Synaptive's third-generation exoscope, which is currently operational in 80 hospitals worldwide.

“We are thrilled to have our first installation in Italy, marketing the debut of Modus X in Europe,” said Cameron Piron, President and Co-founder, Synaptive Medical. “This installation will help push at the boundaries of surgical visualization for Azienda Ospedaliera Universitaria Federico II and support it in its mission to redefine surgical standards.”

“The addition of the Modus X will help enable our surgeons to perform even more effective and precise interventions for the benefit of our patients,” said Professor Paolo Cappabianca, Director of Neurosurgery. “We are particularly enthusiastic about the fluorescence-guided features of the exoscope, which will significantly enhance our capabilities.”

“As the Italian distributors of the Synaptive Modus X Exoscope, we are honored to introduce this cutting-edge technology to the Neurosurgical community in Napoli's AOU Federico II. The arrival of the Modus X is a significant advancement that will revolutionize surgical procedures, offering enhanced precision and visual clarity. We are immensely proud to have facilitated the introduction of the first system in Europe right here in Napoli, marking a pivotal moment in advancing healthcare excellence,” commented Fulvio Albano, President of TEKIM.

Modus X is a pivotal component of Synaptive's integrated suite of products, bridging the gap between mid-field MRI, surgical planning and navigation, and surgical visualization. These devices are engineered to automate critical patient data throughout the surgical process, ultimately improving clinical decision-making.

Synaptive has operations in 15 countries worldwide, solidifying its global presence in advancing medical technology to support patient health.


About Synaptive Medical Inc.
Synaptive Medical Inc., a Toronto-based, high growth global medical technology company, solves surgical, imaging, and data challenges to improve the quality of human lives. Synaptive’s integrated suite of products – bridging MRI, surgical planning, navigation, and robotic visualization – delivers patient-centric information with automated efficiency across all stages of clinical interventions.